Abstract:Post-marketing surveillance is the principal means to ensure drug use safety. The spontaneous report is the essential method of post-marketing surveillance for drug safety. Often, most spontaneous reports come from medical staff and sometimes come from patients who use the drug. The posts published by individuals on social media platforms that contain drugs and related adverse reaction content have gradually been seen as a new data source similar to spontaneous reports from drug users in recent years. Those user-generated posts potentially provide researchers and regulators with new opportunities to conduct post-marketing surveillance for drug safety from patients' perspectives mostly rather than medical professionals and can afford the possibility theoretically to discover drug-related safety issues earlier than traditional methods. Social media data as a new data source for safety signal detection and signal reinforcement have the unique advantages, such as population coverage, type of drugs, type of adverse reactions, data timeliness and quantity. Most of the social media data used in post-marketing surveillance research for drug safety are still text data in English, and even multiple languages are used by different people worldwide on several social media platforms. Unfortunately, there is still a controversy in the academic circles whether social media data can be used as reliable data sources for routine post-marketing surveillance for drug safety. A couple of obstacles of data, methods and ethics must be overcome before leveraging social media data for post-marketing surveillance. The number of Chinese social media users is large, and the social media data in the Chinese language is rapidly snowballing, which can be employed as the potential data source for post-marketing surveillance for drug safety. However, due to the Chinese language's specific characteristics, the text's diversity is different from the English text, and there is not enough accepted corpus in medical scenarios. Besides, the lack of domestic laws and regulations on privacy and security protection of social media data poses more challenges for applying Chinese social media data for post-market surveillance. The significance of social media data to post-marketing surveillance for drug safety is undoubtedly significant. It will be an essential development direction for future research to overcome the challenges of using social media data by developing new technologies and establishing new mechanisms.

Development Trends of the Post-Marketing Drug Safety Surveillance Systems in EU and US

The Principle and the Design Framework of Over-the-counter Pharmaceutical Sales Surveillance

The present situation and prospect in post-marketing surveillance of drug safety

Interpretation of the Drug Post-marketing Intensive Surveillance Policy in China

Present situation of drug safety early warning in China and the solution

[Utilizing social media data in post-market safety surveillance]

Review and Analysis of Active Post-marketing Surveillance Modes for Vaccine Safety

Pharmacovigilance in China: Evolution and future challenges.

Comparative Study on Monitoring System of Medical Device Adverse Events in America, European Union and China

Pharmacovigilance in China: A review

A Systematic Review and Qualitative Analysis or the Definition and Scope of Drug Safety in China

Feasibility of Post-Marketing Active Safety Surveillance for Pediatric Medication Based on Big Medical Data: a Survey on Information Systems in 17 Children′s Hospitals in China

Develop the active surveillance system for vaccine safety in China

A Study On The Function Of Medical Device Postmarket Monitoring Technical System In China

Evaluation of Electronic Healthcare Databases for Post-Marketing Drug Safety Surveillance and Pharmacoepidemiology in China

Recent Advances in Drug Development and Regulatory Science in China

Technical specifications for hospital-based intensive monitoring of post-marketing Chinese patent medicine

[Better medical devices regulations for better health care: enlightenment for medical devices regulatory reform in China, from experiences of the E.U. and the U.S.A]

The Enlightenment of the Management of EU Notified Bodies to China's Introduction of Third-Party Institutions for Medical Device Supervision

[Research on the issues in the process of post-market surveillance for medical devices based on the typical case analysis]

Supervision System of AI-based Software As a Medical Device